145 related articles for article (PubMed ID: 27558018)
1. Angiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice.
Shi L; Yu B; Cai CH; Huang JD
AMB Express; 2016 Dec; 6(1):56. PubMed ID: 27558018
[TBL] [Abstract][Full Text] [Related]
2. Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models.
Liang K; Liu Q; Li P; Han Y; Bian X; Tang Y; Kong Q
Cancer Gene Ther; 2018 Aug; 25(7-8):167-183. PubMed ID: 29755110
[TBL] [Abstract][Full Text] [Related]
3. Development of Oxytolerant Salmonella typhimurium Using Radiation Mutation Technology (RMT) for Cancer Therapy.
Gao S; Jung JH; Lin SM; Jang AY; Zhi Y; Bum Ahn K; Ji HJ; Hyang Lim J; Guo H; Choy HE; Lim S; Seo HS
Sci Rep; 2020 Feb; 10(1):3764. PubMed ID: 32111878
[TBL] [Abstract][Full Text] [Related]
4. Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.
Lee CH; Wu CL; Shiau AL
J Gene Med; 2004 Dec; 6(12):1382-93. PubMed ID: 15468191
[TBL] [Abstract][Full Text] [Related]
5. Optimized Attenuated
Liang K; Zhang R; Luo H; Zhang J; Tian Z; Zhang X; Zhang Y; Ali MK; Kong Q
Front Microbiol; 2021; 12():774490. PubMed ID: 35003007
[TBL] [Abstract][Full Text] [Related]
6. Combined prokaryotic-eukaryotic delivery and expression of therapeutic factors through a primed autocatalytic positive-feedback loop.
Shi L; Yu B; Cai CH; Huang W; Zheng BJ; Smith DK; Huang JD
J Control Release; 2016 Jan; 222():130-40. PubMed ID: 26682504
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
8. Obligate anaerobic
Yu B; Shi L; Zhang BZ; Zhang KE; Peng X; Niu HB; Qu JL
Oncol Lett; 2015 Aug; 10(2):1069-1074. PubMed ID: 26622627
[TBL] [Abstract][Full Text] [Related]
9. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β.
Kim JE; Phan TX; Nguyen VH; Dinh-Vu HV; Zheng JH; Yun M; Park SG; Hong Y; Choy HE; Szardenings M; Hwang W; Park JA; Park S; Im SH; Min JJ
Theranostics; 2015; 5(12):1328-42. PubMed ID: 26516371
[TBL] [Abstract][Full Text] [Related]
10. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors.
Forbes NS; Munn LL; Fukumura D; Jain RK
Cancer Res; 2003 Sep; 63(17):5188-93. PubMed ID: 14500342
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment.
Yoon W; Yoo Y; Chae YS; Kee SH; Kim BM
Ann Oncol; 2018 Sep; 29(9):2010-2017. PubMed ID: 30016386
[TBL] [Abstract][Full Text] [Related]
12. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer.
Zhao M; Geller J; Ma H; Yang M; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10170-4. PubMed ID: 17548809
[TBL] [Abstract][Full Text] [Related]
14. Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors.
Drees JJ; Mertensotto MJ; Augustin LB; Schottel JL; Saltzman DA
J Cancer; 2015; 6(9):843-8. PubMed ID: 26284135
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium.
Jeong JH; Kim K; Lim D; Jeong K; Hong Y; Nguyen VH; Kim TH; Ryu S; Lim JA; Kim JI; Kim GJ; Kim SC; Min JJ; Choy HE
PLoS One; 2014; 9(1):e80050. PubMed ID: 24416126
[TBL] [Abstract][Full Text] [Related]
16. Employment of Salmonella in Cancer Gene Therapy.
Lee CH
Methods Mol Biol; 2016; 1409():79-83. PubMed ID: 26846804
[TBL] [Abstract][Full Text] [Related]
17. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
Lu XL; Jiang XB; Liu RE; Zhang SM
Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
[TBL] [Abstract][Full Text] [Related]
18. Targeted Cancer Therapy Using Engineered Salmonella typhimurium.
Zheng JH; Min JJ
Chonnam Med J; 2016 Sep; 52(3):173-84. PubMed ID: 27689027
[TBL] [Abstract][Full Text] [Related]
19. Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector.
Zheng LM; Luo X; Feng M; Li Z; Le T; Ittensohn M; Trailsmith M; Bermudes D; Lin SL; King IC
Oncol Res; 2000; 12(3):127-35. PubMed ID: 11216671
[TBL] [Abstract][Full Text] [Related]
20. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
